Bioregenx (BRGX) Retained Earnings (2021 - 2026)

Bioregenx's Retained Earnings history runs 6 years deep, the most recent figure standing at -$37.1 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 3.64% year-over-year to -$37.1 million in Q1 2026; TTM through Mar 2026 was -$37.1 million, a 3.64% decrease from a year earlier, with the FY2025 full-year figure at -$37.1 million, down 219.86% from the prior year.
• Retained Earnings held at -$37.1 million in Q1 2026 per BRGX's latest filing, from -$37.1 million in the prior quarter.
• Across five years, Retained Earnings topped out at $31.0 million in Q4 2024 and bottomed at -$37.1 million in Q1 2026.
• The 5-year median for Retained Earnings is -$9.6 million (2023), against an average of -$12.3 million.
• Biggest YoY gain for Retained Earnings was 3287263.91% in 2024; the steepest drop was 622.15% in 2024.
• Year by year, Retained Earnings stood at -$2.9 million in 2022, then soared by 99.97% to -$942.0 in 2023, then soared by 3287263.91% to $31.0 million in 2024, then tumbled by 219.86% to -$37.1 million in 2025, then fell by 0.07% to -$37.1 million in 2026.
• Per Business Quant, the three latest BRGX Retained Earnings figures stand at -$37.1 million (Q1 2026), -$37.1 million (Q4 2025), and -$36.1 million (Q3 2025).